Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Flepp

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
BMJ (Clinical Research Ed.)|December 11, 1997
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort StudyM Egger, B Hirschel, P Francioli, et al.
AIDS (London, England)|October 2, 2001
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort StudyA C Friedl, B Ledergerber, M Flepp, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2006
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapyS Bertschy, M Opravil, M Cavassini, et al.
AIDS (London, England)|December 28, 2000
Acceleration of confirmed coronary artery disease among HIV-infected patients on potent antiretroviral therapyA C Friedl, C H Attenhofer Jost, C Schalcher, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 1999
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort StudyS Bassetti, M Battegay, H Furrer, et al.
Schweizerische Medizinische Wochenschrift|April 5, 1986
[Transfusion-associated LAV/HTLV-III infections in Switzerland. Report of 2 cases]M Flepp, M G Täuber, R Lüthy, et al.
Swiss Medical Weekly|October 20, 2001
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapyM Rossi, M Flepp, A Telenti, et al.
HIV Medicine|December 12, 2001
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patientsM Battegay, P L Vernazza, E Bernasconi, et al.
AIDS (London, England)|March 10, 2001
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre studyH Furrer, M Opravil, M Rossi, et al.
AIDS (London, England)|August 1, 1997
Effect of antiviral treatment on the shedding of HIV-1 in semenP L Vernazza, B L Gilliam, M Flepp, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
BMJ (Clinical Research Ed.)|December 11, 1997
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort StudyM Egger, B Hirschel, P Francioli, et al.
AIDS (London, England)|October 2, 2001
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort StudyA C Friedl, B Ledergerber, M Flepp, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2006
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapyS Bertschy, M Opravil, M Cavassini, et al.
AIDS (London, England)|December 28, 2000
Acceleration of confirmed coronary artery disease among HIV-infected patients on potent antiretroviral therapyA C Friedl, C H Attenhofer Jost, C Schalcher, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 1999
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort StudyS Bassetti, M Battegay, H Furrer, et al.
Schweizerische Medizinische Wochenschrift|April 5, 1986
[Transfusion-associated LAV/HTLV-III infections in Switzerland. Report of 2 cases]M Flepp, M G Täuber, R Lüthy, et al.
Swiss Medical Weekly|October 20, 2001
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapyM Rossi, M Flepp, A Telenti, et al.
HIV Medicine|December 12, 2001
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patientsM Battegay, P L Vernazza, E Bernasconi, et al.
AIDS (London, England)|March 10, 2001
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre studyH Furrer, M Opravil, M Rossi, et al.
AIDS (London, England)|August 1, 1997
Effect of antiviral treatment on the shedding of HIV-1 in semenP L Vernazza, B L Gilliam, M Flepp, et al.
Pageof 7